Session#2
Medical Device
Tuesday, March 14
1:00 – 2:00pm ET

Vivifi Medical is developing minimally invasive surgical (laparoscopic and robotic) device for reversal of Benign Prostate Hyperplasia (BPH) through a quick-and-easy vascular intervention. 12M+ men are currently under treatment for BPH in the US alone. Most existing treatments provide temporary symptomatic relief only (nocturia), at the cost of relief-duration (up to 50% recurrence), urinary and sexual complications. BPH can be reversed by minimizing prostate’s exposure to testosterone, redirecting testosterone-rich blood away from the prostate. This is best achieved by replumbing the pelvic vasculature via vascular anastomosis. Our first-of-its-kind medical device performs just that through a small incision. Subsequent to getting marketing approval for BPH, the company will target other applications in Mens Health (male infertility, low testosterone, Prostate Cancer) and Womens Health (Pelvic pain, pelvic congestion syndrome, uterine fibroid, endometriosis, nutcracker syndrome)

Contact Us:

Tushar Sharma
tushar@vivifimedical.com